NOVEL TRICYCLIC COMPOUNDS

The invention provides a compound of Formula (Ia), (Ib), (Ic), (Id), (Ie), (If), (Ig), (Ih), (Ii), (Ij), (Ik), or (Il) as defined herein, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The comp...

Full description

Saved in:
Bibliographic Details
Main Authors WOLLER KEVIN R, FRANK KRISTINE E, HOEMANN MICHAEL Z, ERICSSON ANNA M, VOSS JEFFREY W, FRIEDMAN MICHAEL, WISHART NEIL, MORYTKO MICHAEL J, CALDERWOOD DAVID J, FIAMENGO BRYAN A, WALLACE GRIER A, WANG LU, JOSEPHSOHN NATHAN S, ARGIRIADI MARIA A, GOEDKEN ERIC R, BREINLINGER ERIC C, GEORGE DAWN M, SOMAL GAGANDEEP, MULLEN KELLY D, LI BIQIN C, STEWART KENT D
Format Patent
LanguageEnglish
Korean
Published 18.09.2012
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention provides a compound of Formula (Ia), (Ib), (Ic), (Id), (Ie), (If), (Ig), (Ih), (Ii), (Ij), (Ik), or (Il) as defined herein, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
Bibliography:Application Number: KR20127016419